Safety Profile of Monoclonal Antibody Compared With Traditional Anticancer Drugs: An Analysis of Henan Province Spontaneous Reporting System Database

Introduction: Monoclonal antibody (mAb) is an important treatment option for cancer patients and has received widespread attention in recent years. In this context, a comparative safety evaluation of mAbs and traditional anticancer drugs in real-world is warranted. Methods: ADR reports submitted to...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiao, Zhiming, Wang, Ganyi, Feng, Zhanchun, Yan, Ziqi, Zhang, Jinwen, Li, Gang, Wang, Qianyu, Feng, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824435/
https://www.ncbi.nlm.nih.gov/pubmed/35145400
http://dx.doi.org/10.3389/fphar.2021.760013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824435/
https://www.ncbi.nlm.nih.gov/pubmed/35145400
http://dx.doi.org/10.3389/fphar.2021.760013

Ejemplares similares